We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.
Our Education Programs
The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:
In the News
An article in the Minnesota Daily highlights state legislative support of valuable spinal cord research at the Stem Cell Institute. Researcher Patrick Walsh (pictured at right) is part of a project led by faculty members Ann Parr and James Dutton to help patients with chronic spinal cord injuries.
The Stem Cell Institute receives many inquiries from patients wanting to know if stem cell therapies are safe and available to help them. It can be confusing to sort out what is claimed from what has been proven. According to the Houston Chronicle, "The Food and Drug Administration recently issued draft guidelines clarifying that the stem cells used in most clinics are drugs and require a rigorous approval process before they can be used in patients. A public hearing is set for April.
Patients considering stem cell therapies can find reputable information at the International Society for Stem Cell Research (ISSCR) website: www.closerlookatstemcells.org.
The University of Minnesota Medical Devices Center has an Objet Connex 260 3D Printer available to create high quality 3D parts. Its ability to use multiple materials in a single applicaion is a great resource for a wide variety of applications:
- General Prototyping
- High Detail Models
- Moving/Dynamic Models
- Multi-Material Models
- Functional Mold Testing
- Suspended Models
Stem Cell Institute faculty member Robert Tranquillo's laboratory is using tissue engineering to develop a heart valve that can grow with children. This would help reduce the number of surgeries these children need to replace outgrown valves. See the whole story at KARE11 news: link.
Weekly Research Conference
Wednesday, February 17, 2016 - 4:00pm
Cell Fate Control by Integrated E2F, FOXO, and AKT Signaling in Retinal Progenitor Cells and Retinoblastoma
Department of Pediatrics
University of Minnesota
Wednesday, February 24, 2016 - 4:00pm
Chemical Control of Oligodendrocyte Fate and Function
Department of Genetics & Genome Sciences
Case Western Reserve University